A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.
New treatments for MG may have a more direct effect on the action of acetylcholine on the neuromuscular junction than steroids, IVIG, and plasmaphoresis.
An update on the prevalence and features of demoralization in patients with PD.
New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.
5 key facts about cerebral microbleeds and risk of future cognitive impairment.
While migraine is distinct from stroke in its gradual onset and lack of focal motor weakness, it is also a predisposing factor for childhood stroke. That can raise the question, “Is it another migraine or is it actually stroke this time?”
With approximately 500 board-certified headache specialists and just over 60 million Americans with headache, the average wait time to see one of us is 3 to 4 months. Technology may hold the key to issues such as this.
Do you know about these handheld noninvasive devices for acute migraines and for migraine prophylaxis? About CGRPs anticipating FDA approval?
Seizure risk can be increased by illicit drug use, withdrawal from alcohol, and opioids or benzodiazepines. Which non-neuro medications can increase seizure risk, even when taken as directed? Test your knowledge in this quiz.
Watching events unfold when humans are subject to public embarrassment can lead to vicarious feelings—and change activity in the brain.
Levels of calcium inside nerve cells seem to decrease early in PD, and then increase later on—a finding that stresses the importance of treatment throughout the entire course of the illness.
5 important facts from a recent double-blind, randomized phase 3 study about siponimod in SPMS.
New technology may help patients and providers assess changes in severity of Parkinson disease symptoms more objectively.
The importance of effective communication and cultural awareness in patient care and outcomes cannot be overstated.
Dr. Abhinav Raina presents his research on the effect of subthalamic nucleus deep brain stimulation on impulsivity in Parkinson disease patients.